You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 2, 2024

Details for Patent: 8,846,744

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,846,744 protect, and when does it expire?

Patent 8,846,744 protects SEGLENTIS and is included in one NDA.

This patent has thirty-eight patent family members in thirty-one countries.

Summary for Patent: 8,846,744

Title:	Pharmaceutical compositions of co-crystals of tramadol and coxibs
Abstract:	The present invention relates to oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib and processes for the preparation of these oral pharmaceutical compositions. The present invention also relates to methods of using oral pharmaceutical compositions comprising co-crystals of tramadol and celecoxib as medicaments, more particularly for the treatment of pain.
Inventor(s):	Soler Ranzani; Luis (Barcelona, ES), Falivene Aldea; Albert (Barcelona, ES)
Assignee:	Laboratorios del Dr. Esteve, S.A. (Barcelona, ES)
Application Number:	13/701,192
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Dosage form;

Drugs Protected by US Patent 8,846,744

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kowa Pharms	SEGLENTIS	celecoxib; tramadol hydrochloride	TABLET;ORAL	213426-001	Oct 15, 2021		RX	Yes	Yes	⤷ Try a Trial	⤷ Try a Trial	Y				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 8,846,744

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	10384002	Jun 4, 2010

PCT Information
PCT Filed	June 03, 2011	PCT Application Number:	PCT/EP2011/002749
PCT Publication Date:	December 08, 2011	PCT Publication Number:	WO2011/151080

International Family Members for US Patent 8,846,744

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	081774	⤷ Try a Trial
Australia	2011260608	⤷ Try a Trial
Brazil	112012030704	⤷ Try a Trial
Canada	2798090	⤷ Try a Trial
China	102946871	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.